159 related articles for article (PubMed ID: 23988828)
1. The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice.
Suski M; Olszanecki R; Stachowicz A; Madej J; Bujak-Giżycka B; Okoń K; Korbut R
Biochim Biophys Acta; 2013 Dec; 1834(12):2463-9. PubMed ID: 23988828
[TBL] [Abstract][Full Text] [Related]
2. AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice.
Toton-Zuranska J; Gajda M; Pyka-Fosciak G; Kus K; Pawlowska M; Niepsuj A; Wolkow P; Olszanecki R; Jawien J; Korbut R
J Physiol Pharmacol; 2010 Apr; 61(2):181-3. PubMed ID: 20436218
[TBL] [Abstract][Full Text] [Related]
3. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice.
Jawien J; Toton-Zuranska J; Gajda M; Niepsuj A; Gebska A; Kus K; Suski M; Pyka-Fosciak G; Nowak B; Guzik TJ; Marcinkiewicz J; Olszanecki R; Korbut R
J Physiol Pharmacol; 2012 Feb; 63(1):77-85. PubMed ID: 22460464
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
Ali Q; Dhande I; Samuel P; Hussain T
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
[TBL] [Abstract][Full Text] [Related]
7. The influence of angiotensin-(1-7) peptidomimetic (AVE 0991) and nebivolol on angiotensin I metabolism in aorta of apoE-knockout mice.
Olszanecki R; Suski M; Gebska A; Toton-Zuranska J; Kus K; Madej J; Bujak-Gizycka B; Jawien J; Korbut R
J Physiol Pharmacol; 2013 Jun; 64(3):317-20. PubMed ID: 23959728
[TBL] [Abstract][Full Text] [Related]
8. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
[TBL] [Abstract][Full Text] [Related]
9. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
[TBL] [Abstract][Full Text] [Related]
10. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.
Pernomian L; do Prado AF; Gomes MS; Pernomian L; da Silva CHTP; Gerlach RF; de Oliveira AM
Eur J Pharmacol; 2015 Oct; 764():173-188. PubMed ID: 26144375
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.
Pinheiro SV; Simões e Silva AC; Sampaio WO; de Paula RD; Mendes EP; Bontempo ED; Pesquero JB; Walther T; Alenina N; Bader M; Bleich M; Santos RA
Hypertension; 2004 Oct; 44(4):490-6. PubMed ID: 15326087
[TBL] [Abstract][Full Text] [Related]
13. Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney.
Jang IA; Kim EN; Lim JH; Kim MY; Ban TH; Yoon HE; Park CW; Chang YS; Choi BS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30424556
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.
Silveira KD; Barroso LC; Vieira AT; Cisalpino D; Lima CX; Bader M; Arantes RM; Dos Santos RA; Simões-E-Silva AC; Teixeira MM
PLoS One; 2013; 8(6):e66082. PubMed ID: 23762470
[TBL] [Abstract][Full Text] [Related]
15. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
16. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
Tiyerili V; Mueller CF; Becher UM; Czech T; van Eickels M; Daiber A; Nickenig G; Wassmann S
J Mol Cell Cardiol; 2012 Mar; 52(3):630-7. PubMed ID: 22230040
[TBL] [Abstract][Full Text] [Related]
18. Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice.
Silva AR; Aguilar EC; Alvarez-Leite JI; da Silva RF; Arantes RM; Bader M; Alenina N; Pelli G; Lenglet S; Galan K; Montecucco F; Mach F; Santos SH; Santos RA
Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(11):R1323-30. PubMed ID: 24089374
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
